A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency
Study sponsor: Agios Pharmaceuticals, Inc. · AGIO
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2017-05-08Actual
Enrollment · participants52Actual
Source updated2026-05-01Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.